The bottleneck of preclinical drug development is the limited availability of suitable animal tumor models that adequately mimic the evolution, the growth kinetics and the overall functional and phenotypic properties of human tumors including their response to developmental drug candidates. Therefore the overall research goal of this consortium is to develop and exploit preclinical tumor models mimicking human tumor growth and progression to substantially advance the war against cancer.

to top
powered by webEdition CMS